Understand the risk and biology of smouldering myeloma (SMM) for early detection of symptomatic myeloma. The study will investigate genomic and immune correlates of progression, clonal heterogeneity, and biomarkers using liquid biopsies and T cell phenotype and functionality in SMM.

4 views • 15 slides

Kate Gregory leads the SWAG Protocols update for March 2024, with advancements in new protocols and NICE TA updates. A comparison of activities from Oct 2023 to Mar 2024 shows progress in issuing, reviewing, and drafting protocols. The latest NICE TA additions include treatments for advanced cancers

5 views • 13 slides

FISH analysis is crucial in multiple myeloma diagnostics, but challenges arise due to low plasma cell detection rates. By isolating CD138+ malignant plasma cells with the EasySep system, sensitivity can be improved for more accurate genetic aberration detection in cytogenetic analyses, aiding in pat

1 views • 12 slides

Explore the general features of lymphoproliferative disorders, including benign causes like infectious mononucleosis and the classification of malignant LPDs. Delve into chronic lymphoid leukemia, along with common LPDs such as Burkitt lymphoma, Follicular lymphoma, multiple myeloma, and Hodgkin lym

0 views • 8 slides

Explore the latest findings from the American Society of Hematology (ASH) 2023 Hybrid Congress regarding Belamaf in multiple myeloma, including real-world outcomes, safety and efficacy analyses, long-term treatment impacts, infection risk, ocular toxicity prevention, and more. Key presentations cove

0 views • 35 slides

Explore the potential dangers of smouldering fires in buildings, their slow-burning nature, and the impact on occupants. Learn about the mechanism of smouldering combustion, its characteristics including low temperature and spread rate, and sources of information from the SFPE Handbook. Discover how

0 views • 17 slides

Cancer patients experiencing pain due to breast, colon, testicular, or multiple myeloma cancer were treated with acupuncture at a Chilean hospital. Results showed significant improvements in quality of life and pain management. Acupuncture proved to be a safe and effective alternative treatment for

0 views • 5 slides

Explore the diagnostic considerations for multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), and related conditions, including indications for serum protein electrophoresis (SPEP) and free light chain (FLC) testing. Learn when not to order SPEP and FLC, and consider various

0 views • 24 slides

This PDF explores the role of Teclistamab in revolutionizing multiple myeloma treatment in India. Learn about its mechanism, benefits, availability, and the future outlook for patients. Discover how Impomed Healthcare is working to enhance access to

0 views • 11 slides

Discover Belantamab Mafodotin 100 mg, a significant advancement in the treatment of relapsed or refractory multiple myeloma in India. This targeted therapy acts on the BCMA protein present on myeloma cells, improving treatment efficacy while minimizing side effects. Explore Belantamab Mafodotin 100

1 views • 11 slides

Elotuzumab in India is an innovative treatment for relapsed or refractory multiple myeloma, targeting SLAMF7 to enhance immune response. With proven clinical success Elotuzumab 300\/400 mg in India, Impomed Healthcare improves accessibility and affor

0 views • 11 slides

Pharmacists provide valuable insights on current and emerging therapeutic regimens for patients with relapsed/refractory multiple myeloma. This includes discussions on efficacy, safety data, regimen design, adverse event management, counseling points, and more. Educational grants support this activi

0 views • 63 slides

Multiple myeloma is a significant hematologic malignancy with varying stages of progression. From the asymptomatic MGUS to the more advanced SMM, early diagnosis and risk stratification are crucial. The presence of myeloma defining events, specific biomarkers, and established criteria guide the diag

0 views • 40 slides